Revised SPCs: Lynparza (olaparib) Film-Coated Tablets

Various sections of the SPC have been updated to take into account its approval for use as monotherapy for the maintenance treatment of adults with metastatic pancreatic adenocarcinoma and germline BRCA1/2-mutations, who have not progressed after platinum-based chemotherapy.

Source:

electronic Medicines compendium